Literature DB >> 1521828

Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His).

C Bögli1, A Hofer, F Baudo, R Redaelli, M Furlan.   

Abstract

An abnormal fibrinogen, denoted as 'fibrinogen Milano IV', has been found in a 36-year-old woman without any bleeding manifestations or thrombotic tendency. Routine coagulation studies revealed prolonged thrombin and reptilase clotting times, very low plasma fibrinogen concentration determined by the functional assay but a normal fibrinogen concentration measured by the immunologic assay. Turbidity curves, measured following addition of thrombin to purified fibrinogen Milano IV, both in presence of calcium or EDTA, were markedly delayed. Release of fibrinopeptide B by thrombin was normal, whereas only half the normal amount of fibrinopeptide A was cleaved. The fibrinopeptide A peak of fibrinogen was preceded by an abnormal fibrinopeptide A*. Both peaks were collected for amino acid analysis which showed an exchange of arginine by histidine in position 16 of the A alpha chain of the fibrinopeptide A*.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1521828     DOI: 10.1159/000216285

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  2 in total

1.  Fibrinogen Milano IV (A alpha 16 Arg-->His): characterization of its abnormal interaction with human alpha-thrombin.

Authors:  R De Cristofaro; M Furlan; R Landolfi
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

2.  A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.

Authors:  Jie Yan; Meiling Luo; Peng Cheng; Lin Liao; Xuelian Deng; Donghong Deng; Faquan Lin
Journal:  Int J Hematol       Date:  2016-12-08       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.